Variant report
Variant | esv3494784 |
---|---|
Chromosome Location | chr6:132106602-132108789 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:23)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:23 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ARID3A | chr6:132108281-132108576 | HepG2 | liver: | n/a | n/a |
2 | CTCF | chr6:132108440-132108590 | HCPEpiC | choroid plexus: | n/a | n/a |
3 | CTCF | chr6:132108480-132108630 | HMF | breast: | n/a | n/a |
4 | CTCF | chr6:132108340-132108490 | BJ | skin: | n/a | n/a |
5 | CTCF | chr6:132107510-132107531 | GM13976 | blood: | n/a | n/a |
6 | CTCF | chr6:132108420-132108570 | HMF | breast: | n/a | n/a |
7 | E2F4 | chr6:132108248-132108523 | MCF10A-Er-Src | breast: | n/a | n/a |
8 | EP300 | chr6:132108292-132108655 | HepG2 | liver: | n/a | chr6:132108371-132108381 |
9 | EP300 | chr6:132108134-132108759 | HepG2 | liver: | n/a | chr6:132108371-132108381 |
10 | FOS | chr6:132108324-132108576 | MCF10A-Er-Src | breast: | n/a | n/a |
11 | FOS | chr6:132108315-132108576 | MCF10A-Er-Src | breast: | n/a | n/a |
12 | FOS | chr6:132108400-132108492 | MCF10A-Er-Src | breast: | n/a | n/a |
13 | FOXA1 | chr6:132108295-132108664 | HepG2 | liver: | n/a | n/a |
14 | FOXA1 | chr6:132108349-132108682 | HepG2 | liver: | n/a | n/a |
15 | FOXA1 | chr6:132108186-132108599 | HepG2 | liver: | n/a | n/a |
16 | FOXA1 | chr6:132108095-132108711 | HepG2 | liver: | n/a | n/a |
17 | FOXA2 | chr6:132108291-132108637 | HepG2 | liver: | n/a | n/a |
18 | NFIC | chr6:132108148-132108722 | HepG2 | liver: | n/a | n/a |
19 | POLR2A | chr6:132106853-132106856 | MCF10A-Er-Src | breast: | n/a | n/a |
20 | SP1 | chr6:132108219-132108601 | HepG2 | liver: | n/a | n/a |
21 | STAT3 | chr6:132108335-132108535 | MCF10A-Er-Src | breast: | n/a | chr6:132108492-132108503 |
22 | STAT3 | chr6:132108317-132108622 | MCF10A-Er-Src | breast: | n/a | chr6:132108492-132108503 |
23 | STAT3 | chr6:132108323-132108628 | MCF10A-Er-Src | breast: | n/a | chr6:132108492-132108503 |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000216917 | TF binding region |
MIR548H5 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs77346327 | chr6:132106632-132106633 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs74868644 | chr6:132106633-132106634 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs566117107 | chr6:132106654-132106655 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs539966556 | chr6:132106680-132106681 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs557817009 | chr6:132106682-132106683 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs569724040 | chr6:132106688-132106689 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs537000740 | chr6:132106750-132106751 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs568327645 | chr6:132106764-132106765 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs187791644 | chr6:132106785-132106786 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs73537644 | chr6:132106819-132106820 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs534594105 | chr6:132106822-132106823 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs553180035 | chr6:132106830-132106831 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs577752620 | chr6:132106906-132106907 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs545100946 | chr6:132106944-132106945 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs79285268 | chr6:132106960-132106961 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs3861469 | chr6:132106988-132106989 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs542612392 | chr6:132107080-132107081 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs13208499 | chr6:132107091-132107092 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs191520081 | chr6:132107132-132107133 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs6926988 | chr6:132107159-132107160 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs183270036 | chr6:132107182-132107183 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs76229548 | chr6:132107229-132107230 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs113432447 | chr6:132107246-132107247 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs551464325 | chr6:132107270-132107271 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs187936076 | chr6:132107290-132107291 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs557004958 | chr6:132107323-132107324 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs62424767 | chr6:132107339-132107340 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs548995411 | chr6:132107345-132107346 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs567550331 | chr6:132107355-132107356 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs114560419 | chr6:132107456-132107457 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs552951942 | chr6:132107504-132107505 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs9493097 | chr6:132107543-132107544 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs191973240 | chr6:132107590-132107591 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs7749523 | chr6:132107607-132107608 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs575447618 | chr6:132107608-132107609 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs185273225 | chr6:132107614-132107615 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs141741927 | chr6:132107623-132107624 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs12660595 | chr6:132107638-132107639 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs541716885 | chr6:132107645-132107646 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs369067934 | chr6:132107656-132107657 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs150584305 | chr6:132107707-132107708 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs190152463 | chr6:132107728-132107729 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs192868196 | chr6:132107742-132107743 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs75659805 | chr6:132107795-132107796 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs138662976 | chr6:132107859-132107860 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs367821293 | chr6:132107867-132107868 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs149560644 | chr6:132107875-132107876 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs376389186 | chr6:132107932-132107933 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs77349927 | chr6:132107954-132107955 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs112053105 | chr6:132108027-132108028 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Autism | 22495311 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Gastric cancer | 17908304 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16272173 | CNVD |
Prostate cancer | 18632612 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Glioma | 21046410 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Zellweger syndrome | 21572526 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21858162 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Chondromyxoid Fibroma | 20696777 | CNVD |
Cancer | 21183584 | CNVD |
Developmental delay | 19490664 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 21785460 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Breast cancer | 17133270 | CNVD |
Follicular lymphoma | 18703704 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Leukemia | 18688285 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:132099800-132109000 | Weak transcription | Skeletal Muscle Male | skeletal muscle |
2 | chr6:132100400-132109400 | Weak transcription | Aorta | Aorta |
3 | chr6:132104200-132107400 | Weak transcription | HepG2 | liver |
4 | chr6:132105800-132108600 | Weak transcription | Adipose Nuclei | Adipose |
5 | chr6:132105800-132109000 | Weak transcription | Fetal Stomach | stomach |
6 | chr6:132106000-132108000 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
7 | chr6:132106200-132107600 | Weak transcription | Foreskin Fibroblast Primary Cells skin02 | Skin |
8 | chr6:132106200-132108800 | Weak transcription | Fetal Muscle Leg | muscle |
9 | chr6:132106200-132109000 | Weak transcription | HSMMtube | muscle |
10 | chr6:132106400-132107600 | Weak transcription | Foreskin Fibroblast Primary Cells skin01 | Skin |
11 | chr6:132106400-132113000 | Weak transcription | Fetal Muscle Trunk | muscle |
12 | chr6:132106600-132107800 | Weak transcription | NHDF-Ad | bronchial |
13 | chr6:132107400-132109600 | Enhancers | HepG2 | liver |
14 | chr6:132107600-132109800 | Enhancers | Foreskin Fibroblast Primary Cells skin02 | Skin |
15 | chr6:132107600-132110800 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
16 | chr6:132107800-132110800 | Enhancers | NHDF-Ad | bronchial |
17 | chr6:132108000-132110600 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
18 | chr6:132108000-132111000 | Enhancers | Muscle Satellite Cultured Cells | -- |
19 | chr6:132108400-132109000 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
20 | chr6:132108600-132109800 | Enhancers | Adipose Nuclei | Adipose |
21 | chr6:132108600-132110600 | Enhancers | NHLF | lung |
22 | chr6:132108600-132111000 | Enhancers | Osteobl | bone |